12 Health Care Stocks Moving In Thursday's Pre-Market Session - Adagene (NASDAQ:ADAG), Aravive (NASDAQ:ARAV)
Stay updated with breaking news from Kronos Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BOSTON, Jan. 8, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the formation of its new Biopharma Advisory
/PRNewswire/ -- DelveInsight's Hematopoietic Stem Cell Transplantation Market Insights report includes a comprehensive understanding of current treatment...
Kronos Bio, Inc. (NASDAQ:KRON – Get Free Report) COO Barbara Kosacz sold 10,676 shares of the business’s stock in a transaction on Thursday, January 4th. The shares were sold at an average price of $1.18, for a total value of $12,597.68. Following the transaction, the chief operating officer now owns 928,966 shares of the company’s […]
Kronos Bio (NASDAQ:KRON – Free Report) had its price target cut by HC Wainwright from $9.00 to $2.50 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately, Piper Sandler dropped their price objective on Kronos Bio from $7.00 to $6.00 and set an […]